Trials / Completed
CompletedNCT04765852
Growth, Safety and Efficacy of a Probiotic Supplement
Growth, Safety and Efficacy of a Probiotic Supplement: a Double-blind, Randomized, Placebo-controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 228 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 14 Days – 21 Days
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to demonstrate the safety of a daily high dose of a probiotic supplement by comparing the growth (weight gain, g/day) of formula-fed and/or breastfed infants in high dose group versus placebo group from enrolment to 8 weeks of intervention
Detailed description
This is a randomized, placebo-controlled, double-blind study of healthy term infants, consisting of three randomized arms: placebo control group, high dose experimental group, and low dose experimental group. The study population, approximately 228, are infants 14 - 21 days of age who are formula-fed and/or breastfed who is aligned with the intended target population for a probiotic supplement. Placebo and probiotic supplements will be mixed with formula or breastmilk and fed orally using a feeding cup or syringe. All enrolled infants will participate in the trial for approximately 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High dose probiotic supplement | One probiotic stick pack will be dissolved in 10 mL lukewarm formula milk or breastmilk at body temperature. The dissolved supplement will be fed orally, preferably in the morning, starting on Day 1 until Day 56. |
| OTHER | Low dose probiotic supplement | One probiotic stick pack will be dissolved in 10 mL lukewarm formula milk or breastmilk at body temperature. The dissolved supplement will be fed orally, preferably in the morning, starting on Day 1 until Day 56. |
| OTHER | Placebo | One placebo stick pack will be dissolved in 10 mL lukewarm formula milk or breastmilk at body temperature. The dissolved supplement will be fed orally, preferably in the morning, starting on Day 1 until Day 56. |
Timeline
- Start date
- 2021-02-26
- Primary completion
- 2021-08-23
- Completion
- 2021-10-12
- First posted
- 2021-02-23
- Last updated
- 2023-03-24
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT04765852. Inclusion in this directory is not an endorsement.